DE3875852T2 - Gereinigtes igm. - Google Patents

Gereinigtes igm.

Info

Publication number
DE3875852T2
DE3875852T2 DE8888111931T DE3875852T DE3875852T2 DE 3875852 T2 DE3875852 T2 DE 3875852T2 DE 8888111931 T DE8888111931 T DE 8888111931T DE 3875852 T DE3875852 T DE 3875852T DE 3875852 T2 DE3875852 T2 DE 3875852T2
Authority
DE
Germany
Prior art keywords
igm
preparation according
less
nucleic acid
acid content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888111931T
Other languages
German (de)
English (en)
Other versions
DE3875852D1 (de
Inventor
George Dove
Gautam Mitra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of DE3875852D1 publication Critical patent/DE3875852D1/de
Application granted granted Critical
Publication of DE3875852T2 publication Critical patent/DE3875852T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DE8888111931T 1987-08-10 1988-07-25 Gereinigtes igm. Expired - Lifetime DE3875852T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8313687A 1987-08-10 1987-08-10

Publications (2)

Publication Number Publication Date
DE3875852D1 DE3875852D1 (de) 1992-12-17
DE3875852T2 true DE3875852T2 (de) 1993-03-18

Family

ID=22176414

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888111931T Expired - Lifetime DE3875852T2 (de) 1987-08-10 1988-07-25 Gereinigtes igm.

Country Status (8)

Country Link
EP (1) EP0303088B1 (enExample)
JP (1) JP2730913B2 (enExample)
AT (1) ATE82136T1 (enExample)
AU (1) AU618745B2 (enExample)
CA (1) CA1341474C (enExample)
DE (1) DE3875852T2 (enExample)
ES (1) ES2045027T3 (enExample)
GR (1) GR3006536T3 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
EP0382031A3 (en) * 1989-02-10 1991-06-26 Miles Inc. Monoclonal antibodies in immune serum globulin
CA2049342A1 (en) * 1989-03-27 1990-09-28 Sally Bolmer Formulations for stabilizing of igm antibodies
CA2086531A1 (en) * 1990-07-03 1992-01-04 Ebo S. Bos Immunoreactive compound
JPH0565233A (ja) * 1991-03-08 1993-03-19 Mitsui Toatsu Chem Inc モノクローナル抗体含有凍結乾燥製剤
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
ATE414537T1 (de) 2001-08-29 2008-12-15 Chugai Pharmaceutical Co Ltd Antikörper enthaltende stabilisierte zubereitungen
EP2204190A1 (en) 2003-07-15 2010-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
WO2005035573A1 (ja) 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha タンパク質溶液の安定化方法
WO2005035574A1 (ja) * 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha IgM高濃度安定化溶液
AU2011210465A1 (en) * 2010-01-29 2012-08-23 Axis Inc. Pharmaceutical composition for treatment or prevention of osteoarthritis, and method of production therefor
US10570194B2 (en) 2015-08-06 2020-02-25 Grifols Worldwide Operations Limited Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
US20240417445A1 (en) * 2023-06-13 2024-12-19 Grifols Worldwide Operations Limited Method for producing a lyophilized composition comprising polyclonal igm and composition obtained

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604235A (en) * 1984-05-23 1986-08-05 J. T. Baker Chemical Company Purification of monoclonal antibodies
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法

Also Published As

Publication number Publication date
ES2045027T3 (es) 1994-01-16
DE3875852D1 (de) 1992-12-17
AU2031588A (en) 1989-06-08
GR3006536T3 (enExample) 1993-06-30
ATE82136T1 (de) 1992-11-15
EP0303088A3 (en) 1989-05-17
EP0303088B1 (en) 1992-11-11
JP2730913B2 (ja) 1998-03-25
EP0303088A2 (en) 1989-02-15
JPH02493A (ja) 1990-01-05
CA1341474C (en) 2005-03-08
AU618745B2 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
DE69223641T2 (de) Stabilisierte antikörper
DE69735295T2 (de) Verfahren zur Aufkonzentrierung von Antikörperlösungen
DE68929061T2 (de) Herstellung humanähnlicher Immunoglobuline und entsprechender Polynukleotide
DE69232617T2 (de) Gefriergetrocknete Zubereitung, die einen monoklonalen Antikörper enthält
DE69228474T2 (de) STABILISIERTE AUFBEREITUNG MONOKLONALER MENSCHLICHER CLN-IgG ANTIKÖRPER
DE68928857T2 (de) Monoklonale Antikörper, die mit Cachectin reagieren
DE69128774T2 (de) GEREINIGTE IgG ANTIKÖRPER
DE69434097T2 (de) Apoptose induzierender monoklonaler antikörper
DE4118912C1 (enExample)
EP0659767B2 (de) Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
EP0260610A2 (de) Monoklonale Antikörper gegen humanen Tumonekrosefaktor (TNF) und deren Verwendung
DE2826075C2 (enExample)
DE69333447T2 (de) Antikörper mit spezifikäten gegen mehrere adhäsionsmoleküle
DE68918673T2 (de) IgG-bindendes Protein H, kodierendes Gen dafür und Verfahren zu seiner Herstellung.
DE69028095T2 (de) M-csf-monoklonale antikörper, die ein neutralisierendes konformationales epitop erkennen
DE3939706C1 (enExample)
EP0085747B2 (de) Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
CA1341474C (en) Purified igm
DE68918761T2 (de) Therapeutische IgM-Konzentrate.
DE69430846T2 (de) Für natürliche killerzellen spezifische antigene und sie identifizierende antikörper
DE68917338T2 (de) Monoklonaler Antikörper mit selektiver Bindung an ein neues g-csf-Derivat.
CH684164A5 (de) Intravenös anwendbare Immunglobulinlösung.
DE3752184T2 (de) Herstellung und Verwendungen von gamma-Interferon
DE69126727T2 (de) Warm-behandelte IGM-Antikörper-Zusammensetzungen
DE68907933T2 (de) Therapeutisches Mittel für Thrombocytopenia.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition